Literature DB >> 9029645

Increased activity of lysosomal acid hydrolases in the cell-free cerebrospinal fluid of bacterial meningitis.

N G Beratis1, T Mavrommatis, I Hatiris, J Kavaliotis, H Tsagaropoulou-Stiga, G A Syrogiannopoulos.   

Abstract

Because inflammation could affect lysosomal enzyme trafficking, resulting in increased enzyme release from the cells, tissue necrosis, or altered blood- and the brain-cerebrospinal fluid (CSF) barrier, the activity of four lysosomal enzymes in the cell-free CSF of 34 patients with bacterial meningitis, 20 with aseptic meningitis, and 39 control subjects was measured. Activities are expressed in nanomoles of 4-methylumbelliferone mL/h. The median beta-hexosaminidase A activity in bacterial meningitis was 313, in aseptic meningitis it was 173, and in the control subjects it was 175, the median beta-hexosaminidase B activity was 417, 165, and 120; the median alpha-mannosidase activity was 171, 124, and 113; and the median beta-glucuronidase activity was 133.7, 14.3, and 10.0, respectively. The difference of the activities of the four enzymes measured between the bacteria meningitis and the controls is significant (p < 0.000). Also significant is the difference between bacterial and aseptic meningitis (p = 0.005 to < 0.000), but it is not significant between aseptic and control subjects. Both the sensitivity and specificity of the beta-glucuronidase activity between bacterial meningitis and control subjects were 100%, whereas the corresponding values between bacterial and aseptic meningitis were 100% and 90%, respectively. No significant correlation was observed between the activities of the enzymes measured and the number of the polymorphonuclear leukocytes or other laboratory characteristics of the CSF. The increased lysosomal enzyme activities in the CSF of patients with meningitis may result from diffusion across the blood-CSF or the brain-CSF barrier or from enzyme leakage through the cell membranes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029645     DOI: 10.1203/00006450-199702000-00014

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.

Authors:  Noha M El-Khodary; Sahar M El-Haggar; Manal A Eid; Emad N Ebeid
Journal:  Med Oncol       Date:  2011-06-05       Impact factor: 3.064

2.  Increased activity of lysosomal enzymes in the peritoneal fluid of patients with gynecologic cancers and pelvic inflammatory disease.

Authors:  N G Beratis; A Kaperonis; M I Eliopoulou; G Kourounis; V A Tzingounis
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

3.  Effect of Lipopolysaccharide-Induced Inflammatory Challenge on β-Glucuronidase Activity and the Concentration of Quercetin and Its Metabolites in the Choroid Plexus, Blood Plasma and Cerebrospinal Fluid.

Authors:  Małgorzata Domżalska; Wiesław Wiczkowski; Aleksandra Szczepkowska; Sylwia Chojnowska; Tomasz Misztal; Fruzsina R Walter; Maria A Deli; Hiroshi Ishikawa; Horst Schroten; Christian Schwerk; Janina Skipor
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

4.  Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid.

Authors:  Emanuele Persichetti; Davide Chiasserini; Lucilla Parnetti; Paolo Eusebi; Silvia Paciotti; Claudia De Carlo; Michela Codini; Nicola Tambasco; Aroldo Rossi; Omar M A El-Agnaf; Omar M El Agnaf; Paolo Calabresi; Tommaso Beccari
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

5.  Intracellular uptake of macromolecules by brain lymphatic endothelial cells during zebrafish embryonic development.

Authors:  Max van Lessen; Shannon Shibata-Germanos; Andreas van Impel; Thomas A Hawkins; Jason Rihel; Stefan Schulte-Merker
Journal:  Elife       Date:  2017-05-12       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.